These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 28724211)
1. Dexmedetomidine preconditioning protects against retinal ischemia/reperfusion injury and inhibits inflammation response via toll-like receptor 4 (TLR4) pathway. Chen Z; Qiu PY; Ma CG Biomed Pharmacother; 2017 Sep; 93():1018-1024. PubMed ID: 28724211 [TBL] [Abstract][Full Text] [Related]
2. Dexmedetomidine preconditioning plays a neuroprotective role and suppresses TLR4/NF-κB pathways model of cerebral ischemia reperfusion. Wang SL; Duan L; Xia B; Liu Z; Wang Y; Wang GM Biomed Pharmacother; 2017 Sep; 93():1337-1342. PubMed ID: 28753906 [TBL] [Abstract][Full Text] [Related]
3. Protective effect of pioglitazone on retinal ischemia/reperfusion injury in rats. Zhang XY; Xiao YQ; Zhang Y; Ye W Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):3912-21. PubMed ID: 23557740 [TBL] [Abstract][Full Text] [Related]
4. Dexmedetomidine Preconditioning Ameliorates Inflammation and Blood-Spinal Cord Barrier Damage After Spinal Cord Ischemia-Reperfusion Injury by Down-Regulation High Mobility Group Box 1-Toll-Like Receptor 4-Nuclear Factor κB Signaling Pathway. Liu J; Zhang S; Fan X; Yuan F; Dai J; Hu J Spine (Phila Pa 1976); 2019 Jan; 44(2):E74-E81. PubMed ID: 29975331 [TBL] [Abstract][Full Text] [Related]
5. Dexmedetomidine Post-Conditioning Alleviates Cerebral Ischemia-Reperfusion Injury in Rats by Inhibiting High Mobility Group Protein B1 Group (HMGB1)/Toll-Like Receptor 4 (TLR4)/Nuclear Factor kappa B (NF-κB) Signaling Pathway. Zhai Y; Zhu Y; Liu J; Xie K; Yu J; Yu L; Deng H Med Sci Monit; 2020 Jan; 26():e918617. PubMed ID: 31912804 [TBL] [Abstract][Full Text] [Related]
6. Dexmedetomidine protects against lung injury induced by limb ischemia-reperfusion via the TLR4/MyD88/NF-κB pathway. Xue BB; Chen BH; Tang YN; Weng CW; Lin LN Kaohsiung J Med Sci; 2019 Nov; 35(11):672-678. PubMed ID: 31373750 [TBL] [Abstract][Full Text] [Related]
7. Dexmedetomidine confers neuroprotection against transient global cerebral ischemia/reperfusion injury in rats by inhibiting inflammation through inactivation of the TLR-4/NF-κB pathway. Kim E; Kim HC; Lee S; Ryu HG; Park YH; Kim JH; Lim YJ; Park HP Neurosci Lett; 2017 May; 649():20-27. PubMed ID: 28392361 [TBL] [Abstract][Full Text] [Related]
8. Dexmedetomidine preconditioning for myocardial protection in ischaemia-reperfusion injury in rats by downregulation of the high mobility group box 1-toll-like receptor 4-nuclear factor κB signalling pathway. Yang YF; Peng K; Liu H; Meng XW; Zhang JJ; Ji FH Clin Exp Pharmacol Physiol; 2017 Mar; 44(3):353-361. PubMed ID: 27998004 [TBL] [Abstract][Full Text] [Related]
9. Dexmedetomidine attenuates cerebral ischemia/reperfusion injury in neonatal rats by inhibiting TLR4 signaling. Cheng J; Zhu P; Qin H; Li X; Yu H; Yu H; Peng X J Int Med Res; 2018 Jul; 46(7):2925-2932. PubMed ID: 29926753 [TBL] [Abstract][Full Text] [Related]
10. Dexmedetomidine Resists Intestinal Ischemia-Reperfusion Injury by Inhibiting TLR4/MyD88/NF-κB Signaling. Yang J; Wu Y; Xu Y; Jia J; Xi W; Deng H; Tu W J Surg Res; 2021 Apr; 260():350-358. PubMed ID: 33383282 [TBL] [Abstract][Full Text] [Related]
11. Toll-like receptor 4 mediates retinal ischemia/reperfusion injury through nuclear factor-κB and spleen tyrosine kinase activation. Ishizuka F; Shimazawa M; Inoue Y; Nakano Y; Ogishima H; Nakamura S; Tsuruma K; Tanaka H; Inagaki N; Hara H Invest Ophthalmol Vis Sci; 2013 Aug; 54(8):5807-16. PubMed ID: 23908181 [TBL] [Abstract][Full Text] [Related]
12. Exercise Preconditioning Regulates the Toll-Like Receptor 4/Nuclear Factor-κB Signaling Pathway and Reduces Cerebral Ischemia/Reperfusion Inflammatory Injury: A Study in Rats. Zhu L; Ye T; Tang Q; Wang Y; Wu X; Li H; Jiang Y J Stroke Cerebrovasc Dis; 2016 Nov; 25(11):2770-2779. PubMed ID: 27590301 [TBL] [Abstract][Full Text] [Related]
13. N-acetylserotonin alleviated the expression of interleukin-1β in retinal ischemia-reperfusion rats via the TLR4/NF-κB/NLRP3 pathway. Liu J; Zhang N; Zhang M; Yin H; Zhang X; Wang X; Wang X; Zhao Y Exp Eye Res; 2021 Jul; 208():108595. PubMed ID: 34000276 [TBL] [Abstract][Full Text] [Related]
15. Dexmedetomidine preconditioning may attenuate myocardial ischemia/reperfusion injury by down-regulating the HMGB1-TLR4-MyD88-NF-кB signaling pathway. Zhang JJ; Peng K; Zhang J; Meng XW; Ji FH PLoS One; 2017; 12(2):e0172006. PubMed ID: 28222157 [TBL] [Abstract][Full Text] [Related]
16. Retinal ischemia/reperfusion injury is mediated by Toll-like receptor 4 activation of NLRP3 inflammasomes. Qi Y; Zhao M; Bai Y; Huang L; Yu W; Bian Z; Zhao M; Li X Invest Ophthalmol Vis Sci; 2014 Aug; 55(9):5466-75. PubMed ID: 25097240 [TBL] [Abstract][Full Text] [Related]
17. Alpha-Lipoic Acid Preconditioning and Ischaemic Postconditioning Synergistically Protect Rats from Cerebral Injury Induced by Ischemia and Reperfusion Partly via Inhibition TLR4/MyD88/ NF-κB Signaling Pathway. Zhang J; Xiao F; Zhang L; Wang X; Lai X; Shen Y; Zhang M; Zhou B; Lang H; Yu P; Hua F Cell Physiol Biochem; 2018; 51(3):1448-1460. PubMed ID: 30485844 [TBL] [Abstract][Full Text] [Related]
18. Ischemic preconditioning protects against myocardial ischemia-reperfusion injury through inhibiting toll-like receptor 4/NF-κB signaling pathway in rats. Yang J; Li Y; Hu C Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Oct; 36(10):972-8. PubMed ID: 22086008 [TBL] [Abstract][Full Text] [Related]
19. Intestinal and Limb Ischemic Preconditioning Provides a Combined Protective Effect in the Late Phase, But not in the Early Phase, Against Intestinal Injury Induced by Intestinal Ischemia-Reperfusion in Rats. Yang B; Chen Y; Long YH; Fan X; Liu KX; Wang XB; Zhou J Shock; 2018 May; 49(5):596-603. PubMed ID: 28786831 [TBL] [Abstract][Full Text] [Related]
20. Dexmedetomidine Protects Rat Liver against Ischemia-Reperfusion Injury Partly by the α2A-Adrenoceptor Subtype and the Mechanism Is Associated with the TLR4/NF-κB Pathway. Wang Y; Wu S; Yu X; Zhou S; Ge M; Chi X; Cai J Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27347929 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]